Enoximone
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Intravenous |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 50% (oral) |
| Protein binding | 85% |
| Metabolism | Hepatic oxidation |
| Elimination half-life | 4 to 10 hours |
| Excretion | Renal (60 to 70%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C12H12N2O2S |
| Molar mass | 248.302 g/mol |
| 3D model (JSmol) | |
| |
|
WikiDoc Resources for Enoximone |
|
Articles |
|---|
|
Most recent articles on Enoximone |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Enoximone at Clinical Trials.gov Clinical Trials on Enoximone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Enoximone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Enoximone Discussion groups on Enoximone Directions to Hospitals Treating Enoximone Risk calculators and risk factors for Enoximone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Enoximone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.[1]
References
- ↑ Boldt J, Suttner S (September 2007). "Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone". Expert Opin Pharmacother. 8 (13): 2135–47. doi:10.1517/14656566.8.13.2135. PMID 17714066.
Template:Phosphodiesterase inhibitors Template:Cardiac stimulants excluding cardiac glycosides
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Cardiovascular Drugs
- Drug
- Phosphodiesterase inhibitors
